Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation — POP ATLANTIS

Severe Aortic Valve Stenosis Clinical Trial

Official title:
Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation: a Pragmatic, International, Multicentre, Randomized Clinical Trial

Status Recruiting

Clinical Trial Summary

The POPular ATLANTIS trial aims to investigate CT-guided antithrombotic therapy compared to lifelong single antiplatelet therapy after a transcatheter aortic valve implantation (TAVI) procedure. Only patients without an indication for anticoagulants will be included in this trial. Currently, lifelong single antiplatelet therapy (mostly aspirin) is considered the standard of care for these patients. However, this approach poses a bleeding risk with only a minimal reduction in thromboembolic events. After 3 months, a CT scan will be conducted to assess the presence of thrombosis on the newly implanted TAVI valve. Based on the results of a 4D CT scan, the decision will be made whether the patient should receive no anticoagulant or antithrombotic therapy with apixaban. CT-guided antithrombotic therapy holds the potential for a greater reduction in thromboembolic events without increasing the bleeding risk.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06168370
Study type	Interventional
Source	St. Antonius Hospital
Contact	Christiaan Overduin
Phone	+31883200931
Email	c.overduin@antoniusziekenhuis.nl
Status	Recruiting
Phase	N/A
Start date	December 1, 2023
Completion date	June 1, 2028

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05552352` - VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease	N/A
Recruiting	`NCT06168123` - Future Optimal Research and Care Evaluation - Aortic Stenosis
Active, not recruiting	`NCT05182307` - DurAVR™ THV System: First-In-Human Study	N/A
Recruiting	`NCT06156592` - Post Spinal Hemodynamic Changes in Aortic Stenosis and Mitral Regurgitation by VIS Index and Echocardiography
Completed	`NCT04259723` - Virtual Reality Assisted Conscious Sedation During TAVI	N/A
Recruiting	`NCT05873816` - The PROTEMBO Trial	N/A
Recruiting	`NCT04128384` - Infranodal Conduction Time During TAVR as Predictor of HAVB	N/A
Recruiting	`NCT05024942` - LUS in Aortic Stenosis Patients Undergoing TAVR
Recruiting	`NCT05283356` - Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation	Phase 4
Not yet recruiting	`NCT05847751` - The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis
Completed	`NCT02224066` - Platelet Reactivity After TAVI: A Multicenter Pilot Study	Phase 4
Recruiting	`NCT05097183` - Validation of Accurate Commissural Alignment During Transcatheter Aortic Valve Implantation
Active, not recruiting	`NCT05712161` - Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study	N/A
Not yet recruiting	`NCT04988243` - Multi Center Registry of Transcatheter Aortic Valve Replacement in Northeast China	N/A